The effectiveness of remifentanil patient-controlled analgesia is not equivalent to that of epidural analgesia for pain relief during labor, study finds.
Remifentanil patient-controlled analgesia is not equivalent to epidural analgesia for pain, pain appreciation scores, and overall satisfaction in women who request pain relief during labor, reported researchers last week at the Society for Maternal-Fetal Medicine’s 34th annual meeting, The Pregnancy Meeting™, in New Orleans.
Remifentanil patient-controlled analgesia (RPCA) is a short-acting pain reliever, an opiate, similar to pethidine. It relieves pain rapidly but wears off quickly, which makes it suitable for administration through patient-controlled analgesia. With RPCA, the patient can give herself a dose of remifentanil intravenously every few minutes. Recent studies have suggested that RCPA was equal to epidural analgesia (EA) in terms of satisfaction with pain relief, so this study-Remifentanil patient-controlled analgesia versus epidural analgesia in labor; a randomized controlled equivalence trial-set out to compare the effectiveness.
Pain appreciation was measured hourly on a visual analog scale and expressed as area under the curve (AUC). The AUC gives a time-weighted measure of total pain appreciation. It was calculated for the duration of labor and for the time that pain relief was administered. A higher AUC for pain appreciation represents higher satisfaction with pain relief.
For the study, 709 women were allocated to RPCA and 705 to EA. They were randomly chosen from healthy pregnant women who intended to deliver vaginally at 15 different hospitals in the Netherlands. During labor, 447 women in the RPCA group and 343 women in the EA group received pain relief. Among women allocated to RPCA, 344 received nothing but RPCA; in the EA group 295 received just EA. Thirteen percent of the women switched to EA after RPCA. The AUC for total pain appreciation during labor was 26.5 in the RPCA group compared with 36.0 in the EA group.
“Recent studies suggest that remifentanil patient-controlled analgesia (RPCA) is equivalent to epidural analgesia (EA) with respect to pain appreciation (satisfaction with pain relief). The aim of our study was to compare the effectiveness of RPCA with EA regarding pain appreciation,” said Liv Freeman, MD, one of the study’s authors.
“The results of the study show that RPCA is not equivalent to EA with respect to pain appreciation, ie, satisfaction with pain relief. Pain appreciation scores in women, who requested pain relief during labor, randomized to EA, are significantly better.”